
Overview
Verco is a Polish pharmaceutical company specializing in gynecology, ophthalmology, and skin care. It offers advanced pharmaceutical products, including dietary supplements like Pregna PLUS for pregnant women, MUCOVAGIN for intimate area hydration, and TRIVAGIN, a leading oral gynecological probiotic. The company collaborates closely with medical professionals and bases its products on scientific research and evidence-based medicine.
Financials
Revenue history (in m)
From the notes
| Current income tax (CIT due) | $2,082,122 |
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 77 days late). 5 of 6 audited by a statutory auditor.
- 202527/06/2026
- 202418/06/2025
- 202326/06/2024
- 202229/06/2023
- 202130/09/2022
- 202029/06/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Offer
- Gynecological products
- Ophthalmic products
- Skincare cosmetics
- Dietary supplements
- Medical devices
Websites
The company has 9 websites. Most of them run on WordPress. The sites are available in: Polish and English. The company measures traffic with Google Analytics and uses the Meta advertising pixel (Facebook, Instagram).
- verco.com.plPolska firma farmaceutyczna Verco – z myślą o kobietachWordPress 3.7Google Tag ManagerYoast SEOPPolylangApache
- afronis.plStrona główna | AfronisWordPress 7.1Google Tag ManagerMeta PixelYoast SEOCloudflareApache
- infectvagin.plStrona główna – InfectVaginWordPress 7.1ElementorRRank MathApache
Public procurement
No recorded participation in tenders.
The company is the contractor in 3 public sector contracts, worth USD 1.20k in total. They were signed with 3 public buyers.
| Signed on | Subject | Amount | Public buyer | |
|---|---|---|---|---|
| Sep 15, 2026 | Onco Radiocalm emulsion | $359.94 | Uniwersytecki Szpital Kliniczny Im.Fryderyka Chopina w Rzeszowie | |
| Aug 19, 2026 | Medical supplies | $680.08 | Zakład Opiekuńczo-Leczniczy | |
| Jul 2, 2026 | Purchase of disinfectants | $159.88 | Kaszubskie Centrum Medyczne w Sierakowicach |
Trademarks
The company holds 133 active trademarks registered with the Polish Patent Office. 4 applications are pending. 43 marks have expired or were not registered. The first mark was filed in 2006.
| Mark | Protected until | |
|---|---|---|
| Bromfedol (word) | Feb 25, 2035 | |
| FOMY (word) | Feb 25, 2035 | |
| Alergeye (word) | Sep 20, 2034 | |
| Oftalergin (word) | Sep 20, 2034 | |
| OFTANAC (word) | May 17, 2034 |
Job offers
The company has its own careers page: verco.com.pl.
Authorized Representatives
Manner of representation
In the case of a one-person management board, the member of the management board makes declarations on behalf of the company independently. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board together with a commercial proxy is required to make declarations on behalf of the company.
Supervisory board
Beneficial owners
| Person | Rights |
|---|---|
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
Ofta sp. z o.o. | 1,350.62 USD | 100% | ||
Ofta Pharma sp. z o.o. | 1,350.62 USD | 100% | ||
Pharma4vet sp. z o.o. | 1,350.62 USD | 100% |
Bank accounts
Registered as a VAT taxpayer on 2006-11-06.
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Buildings and premises | PLN 150.5KPLN 150,533 |
MSiG notices
9 notices recorded in the Court and Commercial Gazette (MSiG).
| Publication date | Event | |
|---|---|---|
| Dec 9, 2025 | Financial statement published | |
| Aug 19, 2024 | Financial statement published | |
| Nov 4, 2020 | Commercial Companies Code notice | |
| Oct 7, 2020 | Commercial Companies Code notice | |
| Sep 22, 2020 | Commercial Companies Code notice |
Public aid
4 public aid cases recorded, with a total value of $953,269.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Nov 10, 2021 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | –– | Prezes Banku Gospodarstwa Krajowego | |
| Nov 6, 2020 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | –– | Prezes Banku Gospodarstwa Krajowego | |
| Nov 6, 2020 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | –– | Prezes Banku Gospodarstwa Krajowego |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Synoptis Pharma sp. z o.o. | $79,311,000.88 | synoptispharma.pl | ||
| Medac Gesellschaft Fur Klinische Spezialpraparate M.B.H. Branch (foreign co.) | $55,460,856.07 | medac.pl | ||
| Wörwag Pharma Operations sp. z o.o. | $46,828,794.87 | woerwagpharma.pl | ||
| DAX Cosmetics sp. z o.o. | $45,596,740.62 | dax.com.pl | ||
| Exim Pharma sp. z o.o. | $24,694,130.27 | eximpharma.eu | ||
| Aristo Pharma sp. z o.o. | $22,775,627.72 | aristo-pharma.pl | ||
| Przedsiębiorstwo Farmaceutyczne Farmapol sp. z o.o. | $21,462,728.43 | farmapol.pl | ||
| Silesian Pharma sp. z o.o. | $20,207,433.45 | silesianpharma.pl | ||
| Vitamed Pharmaceuticals sp. z o.o. | $14,515,124.01 | vitamed.pl | ||
| Wellmedica sp. z o.o. | $11,571,717.59 | wellmedica.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-02-07 | Switch to PKD 2025 (5 PKD 2007 codes → 5 PKD 2025 codes) | |
| 2024-10-03 | Share capital increase (504,397.00 PLN → 504,397.60 PLN) | |
| 2024-09-12 | Share capital reduction (636,938.80 PLN → 504,397.00 PLN) | |
| 2022-10-14 | Share capital increase (635,288.40 PLN → 636,938.80 PLN) | |
| 2022-07-22 | Share capital reduction (874,632.20 PLN → 635,288.40 PLN) |
FAQ
Last updated: 2026-08-24
